CINECA IRIS Institutional Research Information System

BARRESI, ELISABETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3185
EU - Europa 2410
AS - Asia 380
AF - Africa 136
OC - Oceania 25
SA - Sud America 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6143
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3028
IT - Italia 1076
SE - Svezia 356
AT - Austria 259
CN - Cina 248
DE - Germania 248
BG - Bulgaria 179
CA - Canada 154
GB - Regno Unito 74
VN - Vietnam 72
CI - Costa d'Avorio 53
RU - Federazione Russa 51
BE - Belgio 40
NG - Nigeria 40
SN - Senegal 38
FR - Francia 37
FI - Finlandia 28
AU - Australia 25
IN - India 21
UA - Ucraina 20
TR - Turchia 17
NL - Olanda 8
PL - Polonia 8
JP - Giappone 6
HU - Ungheria 5
BR - Brasile 4
EG - Egitto 4
RO - Romania 4
CH - Svizzera 3
KR - Corea 3
TW - Taiwan 3
CL - Cile 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
EE - Estonia 2
ES - Italia 2
HK - Hong Kong 2
HR - Croazia 2
SG - Singapore 2
AZ - Azerbaigian 1
BD - Bangladesh 1
DZ - Algeria 1
EU - Europa 1
GR - Grecia 1
ID - Indonesia 1
IE - Irlanda 1
IL - Israele 1
JM - Giamaica 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MC - Monaco 1
MD - Moldavia 1
MX - Messico 1
PA - Panama 1
Totale 6143
Salva come PNG Salva come JPEG
Città #
Serra 560
Woodbridge 393
Fairfield 363
Ann Arbor 343
Chandler 339
Houston 302
Vienna 222
Sofia 179
Ashburn 155
Seattle 147
Ottawa 146
Wilmington 130
Beijing 118
Princeton 109
Cambridge 105
Frankfurt am Main 92
Lawrence 78
Medford 73
Des Moines 70
Abidjan 53
Dearborn 47
Bremen 42
Rho 41
Brussels 40
Lagos 40
Dakar 38
London 36
Nanjing 31
Pisa 27
Dong Ket 25
Sydney 22
Boulder 20
Florence 20
San Diego 18
Izmir 15
Jacksonville 15
Pistoia 13
Redwood City 13
Alessandria 12
Changsha 12
Hefei 12
Kunming 11
Shenyang 11
Vercelli 11
Nanchang 10
Santa Margherita Ligure 10
Lancaster 9
Livorno 9
Vicopisano 9
Jiaxing 8
Norwalk 8
Toronto 8
Auburn Hills 7
Gif-sur-yvette 7
Hebei 7
Milan 7
Nürnberg 7
Rome 7
Tianjin 7
Arezzo 6
Cascina 6
Citta 6
Falls Church 5
Garbagnate Milanese 5
Hangzhou 5
Lucca 5
Paris 5
Scafati 5
Warsaw 5
Amsterdam 4
Boardman 4
Budapest 4
Castelnuovo di Garfagnana 4
Dortmund 4
Edinburgh 4
Guangzhou 4
Jinan 4
Marseille 4
New York 4
Philadelphia 4
Salerno 4
Tokyo 4
Gaeta 3
Jüchen 3
Los Angeles 3
Omegna 3
Phoenix 3
Solan 3
Taipei 3
Agrate Brianza 2
Cairo 2
Castelfidardo 2
Cecina 2
Central 2
Dallas 2
Gallarate 2
Geneva 2
Genoa 2
Grosseto 2
Helsinki 2
Totale 4817
Salva come PNG Salva come JPEG
Nome #
TSPO ligand residence time influences human glioblastoma multiforme cell death/life balance 238
Apoptosis Therapy in Cancer: The First Single-molecule Co-activating p53 and the Translocator Protein in Glioblastoma 208
Allosteric modulators of human A2B adenosine receptor. 174
Benzofuroxane Derivatives as Multi Effective Agents for the Treatment of Cardiovascular Diabetic Complications. Synthesis, Functional Evaluation, and Molecular Modeling Studies 165
TSPO ligand residence time: a new parameter to predict compound neurosteroidogenic efficacy 158
TSPO PIGA ligands promote neurosteroidogenesis and human astrocyte well-being 154
Deepening the Topology of the Translocator Protein Binding Site by Novel N,N-Dialkyl-2-arylindol-3-ylglyoxylamides 152
Iminothioethers as Hydrogen Sulfide Donors: From the Gasotransmitter Release to the Vascular Effects 144
Arylthioamides as H2S Donors:l-Cysteine-Activated Releasing Properties and Vascular Effects in Vitro and in Vivo 139
Drug-target Residence Time: a key parameter in glial responses to TSPO ligands 138
Residence Time (RT), a new parameter to predict neurosteroidogenic efficacy of Translocator Protein (TSPO) ligands: N,N-dialkyl-2-arylindol-3-ylglyoxylamides, a case study 136
Modulation of A2B Adenosine Receptor by 1-Benzyl-3-ketoindole Derivatives 128
null 124
Modulation of A2B adenosine receptor by 1-benzyl-3-ketoindole derivatives 120
Sulfonamides incorporating heteropolycyclic scaffolds show potent inhibitory action against carbonic anhydrase isoforms I, II, IX and XII 120
Long lasting inhibition of Mdm2-p53 interaction potentiates mesenchymal stem cell differentiation into osteoblasts 119
Phenylpyrazolo[1,5-a]quinazolin-5(4H)-one: a suitable scaffold for the development of non-camptothecin Topoisomerase I (Top1) inhibitors 115
Lead Optimization of 2-Phenylindolylglyoxylyldipeptide Murine Double Minute (MDM)2/Translocator Protein (TSPO) Dual Inhibitors for the Treatment of Gliomas 102
An update into the medicinal chemistry of translocator protein (TSPO) ligands 102
An irreversible ligand of the 18 kDa Translocator Protein induces rapidly ΔΨm collapse and activates apoptosis in human glioblastoma multiforme cells. 101
Novel fluorescent triazinobenzimidazole derivatives as probes for labelling human A1 and A2B adenosine receptor subtypes 101
Long lasting MDM2/Translocator protein modulator: a new strategy for irreversible apoptosis of human glioblastoma cells 98
3-Aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one: a novel template for the design of highly selective A(2B) adenosine receptor antagonists 95
Allosteric modulation of A2B adenosine receptors potentiate the effects of orthosteric receptor agonists to promote mesenchymal stem cell differentiation to osteoblasts. 94
Exploiting the 4-Phenylquinazoline Scaffold for the Development of High Affinity Fluorescent Probes for the Translocator Protein (TSPO) 94
Novel positive allosteric modulators of A2B adenosine receptor acting as bone mineralisation promoters 93
Structure-Activity Relationship Refinement and Further Assessment of 4-Phenylquinazoline-2-carboxamide Translocator Protein Ligands as Antiproliferative Agents in Human Glioblastoma Tumors. 93
3-Aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one: A Novel Template for the Design of Highly Selective A(2B) Adenosine Receptor Antagonists. 91
Benzothiopyranoindole- and pyridothiopyranoindole-based antiproliferative agents targeting topoisomerases 90
4-Substituted Benzenesulfonamides Incorporating Bi/Tricyclic Moieties Act as Potent and Isoform-Selective Carbonic Anhydrase II/IX Inhibitors 89
Translocator protein (tspo) ligand residence time: a new parameter to predict neurosteroidogenic efficacy for n,n-dialkyl-2-arylindol-3-ylglyoxylamides (PIGAs) 85
Discovery of Pyrido[3′,2′:5,6]thiopyrano[4,3- d]pyrimidine-Based Antiproliferative Multikinase Inhibitors 82
A mixed-valence diruthenium(ii,iii) complex endowed with high stability: from experimental evidence to theoretical interpretation 79
Unbinding of Translocator Protein 18 kDa (TSPO) Ligands: From in Vitro Residence Time to in Vivo Efficacy via in Silico Simulations 76
Glioblastoma multiforme: induction of mitochondria-mediated apoptotic pathway by simultaneous pharmacological activation of TSPO (18KDa) and p53. 74
Studies on enantioselectivity of chiral 4-acetylamino-6-alkyloxy-2-alkylthiopyrimidines acting as antagonists of the human A3 adenosine receptor 73
Design and synthesis of novel indolylglyoxylamide derivatives as molecular probes for 18 KDa translocator protein (TSPO) 71
Two mixed valence diruthenium(ii,iii) isomeric complexes show different anticancer properties 70
Phenylpyrazolo[1,5-a]quinazolin-5(4H)-one: a suitable scaffold for the development of noncamptothecin Topoisomerase I (top1) inhibitors 67
2-(phenylsulphonamido)-pyrazole derivatives as carbonic anhydrase inhibitors 66
Refinement of the Mitochondrial Translocator Protein Pharmacophore/Receptor Model via Structure-activity Relationships of Novel N,N-Dialkylindolylglyoxylamides 66
New insights in the structure-activity relationships of 2-phenylamino-substituted benzothiopyrano[4,3-d]pyrimidines as kinase inhibitors 65
Carbonic anhydrase activation profile of indole-based derivatives 65
Inhibition studies on carbonic anhydrase isoforms I, II, IV and IX with N-arylsubstituted secondary sulfonamides featuring a bicyclic tetrahydroindazole scaffold 65
Interaction of the irreversible ligand IRDE-MPIGA with TSPO (18 KDa): new insight on TSPO role in tumor cells. 64
Refinement of the translocator protein pharmacophore/receptor model via structure-activity relationships of novel N,N-dialkylindolylglyoxylamides 63
null 63
De novo neurosteroidogenesis in human microglia: Involvement of the 18 kda translocator protein 63
Allosterism vs. Orthosterism: Recent Findings and Future Perspectives on A2B AR Physio-Pathological Implications 61
Iminothioethers As A Novel Class Of H2s-Donor: Gasotransmitter Release And Vascular Effects 59
The Alpha Keto Amide Moiety as a Privileged Motif in Medicinal Chemistry: Current Insights and Emerging Opportunities 55
Iminothioethers as a novel class of H2S-donor: gasotransmitter release and vascular effects 53
Multiple Topoisomerase I (TopoI), Topoisomerase II (TopoII) and Tyrosyl-DNA Phosphodiesterase (TDP) inhibitors in the development of anticancer drugs 52
3-Aryl-1,2,4-triazino-4,3-abenzimidazol-4(10H)-one: a novel template for the design of highly selective A2B adenosine receptor antagonists 51
Development of a New A2B Adenosine Receptors PET ligand: 3- Phenyl-1-[11C]methyl-3- aryl[1,2,4]triazino[4,3 -a]benzimidazol-4(10H)-one 49
Tetrahydroquinazole-based secondary sulphonamides as carbonic anhydrase inhibitors: synthesis, biological evaluation against isoforms I, II, IV, and IX, and computational studies 49
N,N-dialkyl-5-isothiocyanato-2-phenylindol-3-ylglyoxylamide: an irreversible ligand to study the translocator protein 48
Benzoxadiazole Derivatives: Atypical Inhibitors of Aldose Reductase 47
Refinement of the Mitochondrial Translocator Protein Pharmacophore/Receptor Model via Structure-activity Relationships of Novel N,N-Dialkylindolylglyoxylamides 44
Lead optimization of a novel molecular scaffold in search for novel MMP-13 inhibitors 43
Strategies for the improvement of metal-based chemotherapeutic treatments 43
New suitable scaffolds for the development of non camptothecin topoisomerase I (Top1) inhibitors 42
Indole-based modulators of p53/MDM2 interaction as antitumoral agents 42
Novel 2-substituted-benzimidazole-6-sulfonamides as carbonic anhydrase inhibitors: synthesis, biological evaluation against isoforms I, II, IX and XII and molecular docking studies 41
Labeling of TSPO PET radioligands by [18F]fluorination of diarylsulfoxide precursors 40
Modulation of PAR1 signaling by benzimidazole compounds 37
Development of novel indole-based tdp1 inhibitors for anticancer therapy 36
Radiosynthesis of the TSPO 18 kDa PET Radiotracer [18F](R)-PK14105 36
Carbonic Anhydrase Activators for Neurodegeneration: An Overview 36
Refinement of the Mitochondrial Translocator Protein Pharmacophore/Receptor Model via Structure-activity Relationships of Novel N,N-Dialkylindolylglyoxylamides. 35
New antiproliferative agents derived from tricyclic 3,4-dihydrobenzo[4,5]imidazo[1,2-a][1,3,5]triazine scaffold: synthesis and pharmacological effects 34
N,N-dialkyl-5-isothiocyanato-2-phenylindol-3-ylglyoxylamide: an irreversible ligand to study the translocator protein 34
Targeting the KRAS oncogene: Synthesis, physicochemical and biological evaluation of novel G-Quadruplex DNA binders 33
Targeting TSPO Reduces Inflammation and Apoptosis in an In Vitro Photoreceptor-Like Model of Retinal Degeneration 26
H2S-releasing properties of new thioamide derivatives 26
Indole-based modulators of p53/MDM2 interaction as antitumoral agents 24
Translocator Protein 18-kDa: a promising target to treat neuroinflammation-related degenerative diseases 24
Essential Principles and Recent Progress in the Development of TSPO PET Ligands for Neuroinflammation Imaging 21
Cancer Immunotherapy: An Overview on Small Molecules as Inhibitors of the Immune Checkpoint PD-1/PD-L1 (2015-2021) 20
Toward PET imaging of A2B adenosine receptors: A carbon-11 labeled triazinobenzimidazole tracer. Synthesis and imaging of a new A2B PET tracer 16
null 16
Drug repurposing meets DNA independent pathways: targeting alternative substrates for anticancer therapy 13
Enriching the arsenal of pharmacological tools against mical2 10
A complex bearing TSPO PIGA ligand coordinated to the [Au(PEt3)]+ pharmacophore is highly cytotoxic against ovarian cancer cells 7
Dual Targeting Topoisomerase/G-Quadruplex Agents in Cancer Therapy-An Overview 7
Target-Based Anticancer Indole Derivatives for the Development of Anti-Glioblastoma Agents 6
Targeting the 18-kDa translocator protein: Recent perspectives for neuroprotection 5
A cyanine-based NIR fluorescent Vemurafenib analog to probe BRAFV600E in cancer cells 3
Diruthenium(ii,iii) paddlewheel complexes: effects of bridging and axial ligands on anticancer properties 2
Totale 6358
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11117
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11117
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201853 0000 00 00 00494
2018/2019523 21463 395 14726 23909969
2019/20201300 1116635161 91122 11796 106689021
2020/2021728 145625312 5524 1461 90635099
2021/20221037 41915339 137166 5546 343445296
2022/20231637 162208128153 154193 46127 34526950
Totale 6358